K183406 is an FDA 510(k) clearance for the CereLink ICP Monitor, CereLink ICP Extension Cable. Classified as Device, Monitoring, Intracranial Pressure (product code GWM), Class II - Special Controls.
Submitted by Integra Lifesciences Corp. (Mansfield, US). The FDA issued a Cleared decision on January 11, 2019 after a review of 32 days - a notably fast clearance cycle.
This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1620 - the FDA neurology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.
Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.